The investment will help prepare the device for volume manufacturing, develop the clinician and patient-led online platform, and achieve first sales.
A company named Seraphin is launching an open platform designed to deliver a digital detox; that...
The US Food and Drug Administration (FDA) has granted commercial clearance for the Cerêve Sleep...
Read MoreThe Food and Drug Administration (FDA) will propose approval and reclassification of cranial electrotherapy stimulation (CES) devices for the treatment of insomnia, depression, and anxiety. In a document to be published...
Read More